In addition, pharmacologically inhibiting CCL2 expression in mice with CCl4 or methionine-choline-deficient (MCD) diet-induced chronic liver injury suppresses monocyte/macrophage migration into the injury liver, resulting in amelioration of hepatic steatosis and inflammation [41]. This evidence concerns the gene CCL2 and fatty liver disease.